News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Ascentage Pharma Group International (HKEX:6855) generated 638.92 million HKD last year, with its top-performing segment, Therapies for Hematological Malignancies, contributing 541.47 million HKD. The majority of this revenue, 622.65 million HKD, came from China. The article provides a breakdown of the company's revenue by …
Sharemaestro market context Price below Trend Line 52 weeks -60.3% · Next-week setup negative 44.0%Ascendis Pharma A/S (ASND) has an institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 111.42%, a slight decrease of 4.32% quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 132.15K shares, which represents …
This article details Masco Corp's lobbying activities in 2021, including their total spending, the number of lobbyists employed, and the firms involved. It identifies three named lobbyists for Masco Corp in 2021, with one in-house and two from the Laurin Baker Group. The content …
BlackRock, Inc. has significantly reduced its stake in Ardmore Shipping Corp (ASC) by selling 986,987 shares, representing a 31.04% trim of its holdings. This transaction, executed at $14.01 per share, occurred on June 30, 2026, and the stock has since appreciated by 24.13%. Ardmore …
Boise Cascade (BCC) has seen an 83.3% gain over the past five years, but its current valuation presents a mixed picture. A Discounted Cash Flow (DCF) analysis suggests the stock is overvalued by 11.7%, while an earnings-based P/E multiple indicates it might be undervalued. …
Boise Cascade's Board of Directors previously approved a 5% increase in its quarterly dividend to US$0.23 per share, payable on September 16, 2026, to shareholders of record as of September 1, 2026. This higher regular dividend underscores the company's focus on returning cash to …
The Gross Law Firm is reminding investors of Erasca, Inc. (NASDAQ: ERAS) about an upcoming deadline for a securities class action lawsuit. Shareholders who purchased ERAS shares between January 14, 2025, and April 26, 2026, are encouraged to contact the firm regarding potential lead …
Robbins LLP is reminding investors of Erasca, Inc. (NASDAQ: ERAS) that a class action lawsuit has been filed against the company. The lawsuit alleges that Erasca failed to disclose that it was at risk of violating patent and trade secret protections and that its …
Masco Corp (NYSE: MAS) reported mixed second-quarter financial results, beating earnings estimates but missing on sales. Following the announcement, Masco raised its full-year 2026 adjusted EPS guidance. Several analysts subsequently adjusted their price targets for the stock, with one downgrading its rating.
Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. Burcon NutraScience Corp (BRCNF) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector …
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong …
Ascentage Pharma's Chairman and CEO, Dr. Dajun Yang, has been recognized on The Medicine Maker Power List 2026, ranking No. 3 in the Small Molecules category. The list honors 60 global leaders driving innovation in drug discovery and development. Dr. Yang's inclusion highlights his …
Masco Corporation reported mixed results for Q2 2026, with earnings and margins sharply improved due to pricing, cost savings, and a significant tariff refund, but sales declined. The company's adjusted earnings per share rose 26% year-over-year, beating estimates, while net sales fell 2.9% and …
This article from Stock Traders Daily provides a detailed analysis of Lemaitre Vascular Inc. (LMAT) focusing on precision trading strategies and risk zones. It highlights near-term strong sentiment, mid-term neutrality, and long-term positive bias, along with specific entry, target, and stop-loss levels for different …
Sei Investments Co. increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 30.7% in the first quarter, now holding 136,674 shares valued at $14.92 million. Other
This article provides the "Price to book forward" financial metric for Erasca, Inc. (NASDAQ: ERAS). It appears to be a stub or data-focused entry from a financial platform, showing the company's ticker, exchange, and the specific financial value along with its change over a …
This article provides a valuation analysis of Ascendis Pharma A/S (ASND), highlighting its current valuation score of 7.87 within the Biotechnology & Medical Research industry. It notes the P/E ratio is 36.18, which is below its recent high but significantly above its recent low. …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Masco (MAS) drew fresh investor focus after second quarter results showed operating profit and earnings per share ahead of analyst expectations, even as revenue came in below …
UBS has maintained a "Buy" rating on Masco (MAS) but lowered its price target from $97.00 to $94.00, reflecting a cautious outlook despite strong company performance. According to GuruFocus, Masco is currently undervalued by 1.5% and boasts a GF Score™ of 88/100, indicating robust …
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) for purchasers of its common stock between January 14, 2025, and April 26, 2026. Investors who suffered substantial losses are encouraged to seek appointment as lead plaintiff …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Masco (NYSE:MAS) has appointed Brad Hiranaga as its first Chief Marketing Officer. The new role focuses on brand growth, digital acceleration, and customer-centric product and …
Boise Cascade Company (NYSE: BCC) announced a 5% increase in its quarterly dividend, raising it by $0.01 to $0.23 per share. This dividend will be paid on September 16, 2026, to stockholders of record as of September 1, 2026. Future dividend declarations are subject …
Boise Cascade Company (BCC) announced a 5% increase in its quarterly dividend to $0.15 per share, payable on September 15, 2026, to shareholders of record as of August 30, 2026. This increase reflects the company's strong financial performance and commitment to returning value to …
Boise Cascade (BCC) has announced a 5% increase in its quarterly cash dividend, raising it to $0.23 per share. This dividend is payable on September 16, 2026, to shareholders of record as of September 1, 2026. Future dividends will be subject to various financial …
MAS Q2 Deep Dive: Revenue Misses Estimates but Profitability Benefits from Tariff Refunds Home-building design and manufacturing company Masco Corporation (NYSE:MAS) fell short of the market's revenue expectations in Q2 CY2026, with sales falling 2.9% year on year to $1.99 billion. Its non-GAAP profit …
This page provides financial information for Ascendis Pharma A/S ADR (A1SN34) traded on BMFBOVESPA. It focuses on the "Price to book forward" metric and lists the company's trading status as "Market closed" with "No trades." The content is primarily a financial data page from …
LeMaitre Vascular Inc (LMAT) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. This score reflects a quarter-over-quarter increase of 8.41% in institutional shareholding proportion, which currently stands at 102.98%. ETHSX is the largest institutional shareholder, …
Levi & Korsinsky, LLP is reminding investors of Erasca, Inc. (NASDAQ: ERAS) about a pending class action lawsuit with a lead plaintiff deadline of August 10, 2026. The lawsuit alleges that Erasca made misleading statements regarding its drug ERAS-0015, particularly concerning its comparisons to …
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Erasca, Inc. (NASDAQ:ERAS) on behalf of investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made false statements and concealed that ERAS-0015's preclinical data …
Ardmore Shipping (ASC) reported strong Q2 2026 earnings, with basic EPS of US$1.48 and revenue of US$116.2m, driven by firm product and chemical tanker markets. The company's profitability and high profit margins caught investors' attention, despite concerns about potential rate normalization and increased future …
Search by ticker symbol or company name and select a result to open its chart. The US only control limits results to active US-listed stocks and ETFs.
Showing active US-listed stocks and ETFs only.